Asston Pharmaceuticals Limited (APL) — BSE Stock Analysis

Sector: Healthcare. Industry: Drug Manufacturers - Specialty & Generic. Share price: ₹73.97.

Company Overview

Asston Pharmaceuticals Limited is a pharmaceutical and nutraceutical manufacturing company founded in 2019 and headquartered in Navi Mumbai, India. The company is principally engaged in the development, production, marketing, and export of a diverse range of healthcare products, including tablets, capsules, syrups, sachets, ointments, creams, gels, lotions, and injectables. Asston Pharmaceuticals maintains a strong operational footprint in both domestic and international markets, with significant export activities targeting West African, South African, and Asian countries. Its production facilities are FDA-certified and operate under WHO-GMP guidelines, ensuring high standards of quality and compliance for its extensive portfolio of over 150 registered trademarks. The company is active in major therapeutic areas, supplying generic medicines, pediatric formulations, anti-tuberculosis treatments, eye drops, and nutritional supplements. Asston Pharmaceuticals employs an asset-light model, combining in-house manufacturing with contract-based production through partnerships with WHO-GMP-certified units. The company's market role is supported by its formulation expertise, broad product offerings, and strategic location near key transport hubs, allowing it to serve both direct customers and multiple corporate clients through contract manufacturing and export channels.

Valuation Snapshot

• Market cap: —
• P/E: —
• P/B: —
• ROE: —

Blanket Finance is not a SEBI-registered investment adviser or research analyst. This content is for educational and informational purposes only.